Andrew Schiff
QuietNamed in filings at Aisling CapitalOn the current fund
- Board seats filed
- 7
- Named on a board
- 0
all filings on record
Named in filings at Aisling CapitalOn the current fund
all filings on record
last 24 months
from a verified or cited source
| Dren Bio | Biotech & pharma | March 2022 | None on file |
| Monte Rosa Therapeutics | Biotech & pharma | March 2021 | Versant Venture Capital |
| Aclaris Therapeutics | Biotech & pharma | August 2017 | Sofinnova Venture Partners, Vivo Innovation |
| AGILE THERAPEUTICS | Not yet classified | April 2014 | None on file |
| PowerVision | Enterprise software | January 2014 | Lightstone Singapore, Lightstone Ventures |
| UPTAKE MEDICAL | Not yet classified | December 2011 | None on file |
| TRANSENTERIX | Robotics & hardware | November 2011 | SV Life Sciences |
The company and date are what the SEC filing shows, not a statement of investment thesis. A partner can sit on a board for reasons that say nothing about what their firm funds today. The sector is not a filing value: it is Lev’s own classification of each company, shown only when we found a specific, checkable source for it; otherwise it reads “Not yet classified.” “Also on the board from” names another tracked firm with a partner on the same board, both with a clean identity match. It is not a claim either firm led or co-led the round, and “None on file” means no other tracked firm’s partner shares this specific board seat, not that no one else invested. Sorted newest first by default; click a column to change it. Something wrong? Tell us.
Classified sectors of companies where filings name Andrew Schiff on the board, based on 5 filed seats with a verified or cited source.
2 more filed seats not yet classified, left out of the shares above.